Filing Details
- Accession Number:
- 0001735276-20-000010
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-11 16:08:59
- Reporting Period:
- 2020-02-10
- Accepted Time:
- 2020-02-11 16:08:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178670 | Alnylam Pharmaceuticals Inc. | ALNY | Pharmaceutical Preparations (2834) | 770602661 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1237564 | M Steven Paul | 675 West Kendall Street Henri A. Termeer Square Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-10 | 30,000 | $14.67 | 31,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-10 | 30,000 | $130.00 | 1,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-02-10 | 30,000 | $0.00 | 30,000 | $14.67 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-09-22 | No | 4 | M | Direct |
Footnotes
- All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2019. The 30,000 options exercised and sold by the reporting person were due to expire on September 22, 2020.
- The stock option vested as to one third of the shares on each of the first, second and third anniversaries of the grant date.
Billionaire Hedge Funds
